Hunan Jiudian Pharmaceutical (SZ:300705)2025-03-27 12:58Group 1: Company Overview and Market Position - The company, Hunan Jiudian Pharmaceutical Co., Ltd., focuses on the production of external anti-inflammatory and analgesic products, specifically Loxoprofen and Ketoprofen gel patches, which are considered complementary in the market [2][3]. - The external patch market in 2023 has a sales scale of approximately ¥20.364 billion, with hospitals accounting for 69.89% and retail for 30.11% [4]. Group 2: Cost Control and Operational Efficiency - The company implements various measures for cost reduction, including self-production of raw materials and key auxiliary materials to ensure product quality while controlling costs [3]. - Continued efforts will be made to expand outpatient markets and optimize marketing models to further reduce sales expenses [5]. Group 3: Strategic Planning and Growth Potential - The company’s 2025 strategic plan focuses on three key areas: expanding sales channels, enhancing R&D for new product development, and optimizing production processes for efficient operations [7]. - There is significant growth potential for Loxoprofen sodium gel patches in the outpatient market, driven by stable demand and increasing consumer preference for convenient medication [8].